tiprankstipranks
Advertisement
Advertisement

JP:4519 Stock Latest News

Chugai Sets Terms for New Trust-Based Stock Compensation Plans
Company AnnouncementsChugai Sets Terms for New Trust-Based Stock Compensation Plans
12d ago
Chugai Results Reflected in Roche’s First-Quarter 2026 Sales Report
PremiumCompany Announcements
Chugai Results Reflected in Roche’s First-Quarter 2026 Sales Report
13d ago
CHGCF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CHGCF Earnings this Week: How Will it Perform?
14d ago
Chugai Clarifies Strategic Alliance and Governance Structure Under Roche Control
PremiumCompany Announcements
Chugai Clarifies Strategic Alliance and Governance Structure Under Roche Control
1M ago
Chugai Weighs Investment Unit Cut to Boost Liquidity and Broaden Investor Base
PremiumCompany Announcements
Chugai Weighs Investment Unit Cut to Boost Liquidity and Broaden Investor Base
1M ago
Chugai, Roche Halt Neuromuscular Trials of Emugrobart but Press On in Obesity
PremiumCompany AnnouncementsChugai, Roche Halt Neuromuscular Trials of Emugrobart but Press On in Obesity
1M ago
Chugai to Replace Restricted Stock with Trust-Based Equity Incentive Plan
Premium
Company Announcements
Chugai to Replace Restricted Stock with Trust-Based Equity Incentive Plan
3M ago
Chugai Pharmaceutical Plans Sharp Dividend Hike with 100th Anniversary Payout, Signals Normalization in 2026
Premium
Company Announcements
Chugai Pharmaceutical Plans Sharp Dividend Hike with 100th Anniversary Payout, Signals Normalization in 2026
3M ago
Chugai’s 2025 Performance Reflected in Parent Roche’s Fiscal Results
PremiumCompany Announcements
Chugai’s 2025 Performance Reflected in Parent Roche’s Fiscal Results
3M ago
CHGCF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CHGCF Earnings this Week: How Will it Perform?
3M ago
Chugai Pharmaceutical Completes Absorption-Type Merger of Renalys Pharma
PremiumCompany Announcements
Chugai Pharmaceutical Completes Absorption-Type Merger of Renalys Pharma
4M ago
Chugai Highlights Positive Phase 3 Results and FDA Filing for Lilly’s Oral GLP-1 Orforglipron
PremiumCompany Announcements
Chugai Highlights Positive Phase 3 Results and FDA Filing for Lilly’s Oral GLP-1 Orforglipron
5M ago
Chugai Pharmaceutical to Merge with Renalys Pharma to Boost Kidney Disease Drug Development
PremiumCompany AnnouncementsChugai Pharmaceutical to Merge with Renalys Pharma to Boost Kidney Disease Drug Development
6M ago
Chugai Pharmaceutical Acquires Renalys Pharma to Expand IgA Nephropathy Treatment
Premium
Company Announcements
Chugai Pharmaceutical Acquires Renalys Pharma to Expand IgA Nephropathy Treatment
6M ago
Chugai Pharmaceutical Reports Strong Q3 Results and Announces Special Dividend
Premium
Company Announcements
Chugai Pharmaceutical Reports Strong Q3 Results and Announces Special Dividend
6M ago
Chugai Pharmaceutical’s Role in Roche’s Q3 2025 Sales Announcement
PremiumCompany Announcements
Chugai Pharmaceutical’s Role in Roche’s Q3 2025 Sales Announcement
6M ago
CHGCF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CHGCF Earnings this Week: How Will it Perform?
7M ago
Chugai Partners with Rani Therapeutics for Innovative Oral Biologics
PremiumCompany Announcements
Chugai Partners with Rani Therapeutics for Innovative Oral Biologics
7M ago
Eli Lilly’s Orforglipron Shows Superior Results in Diabetes Trial
PremiumCompany Announcements
Eli Lilly’s Orforglipron Shows Superior Results in Diabetes Trial
8M ago
Chugai Announces Positive Phase 3 Results for Eli Lilly’s Orforglipron
PremiumCompany AnnouncementsChugai Announces Positive Phase 3 Results for Eli Lilly’s Orforglipron
8M ago
Chugai Highlights Eli Lilly’s Positive Phase 3 Results for Orforglipron
Premium
Company Announcements
Chugai Highlights Eli Lilly’s Positive Phase 3 Results for Orforglipron
9M ago
Chugai Pharmaceutical Reports Strong H1 2025 Performance
Premium
Company Announcements
Chugai Pharmaceutical Reports Strong H1 2025 Performance
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >